Article
Efficacy estimates of oral pre-exposure prophylaxis for HIV prevention in cisgender women with partial adherence - Nature Medicine
Rating:
0.0
Views:
69
Likes:
1
Library:
1
Pre-exposure prophylaxis (PrEP) with tenofovir (TFV) disoproxil fumarate and emtricitabine administered orally daily is effective in preventing human immunodeficiency virus (HIV) acquisition in both men and women with sufficient adherence; however, the adherence–efficacy relationship in cisgender women has not been well established.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value